USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
US Digital Therapeutics Market, Forecast to 2023
US Digital Therapeutics Market, Forecast to 2023
Many New Services Evolving from Digital Health and mHealth are Expected to Drive Growth, Reduce Healthcare Costs, and Improve Patient Outcomes
RELEASE DATE
25-May-2018
25-May-2018
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: K270-01-00-00-00
SKU: HC03014-NA-MR_21949
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC03014-NA-MR_21949
Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023.
This report emphasizes the importance of clearly defining the term "digital therapeutics." In many areas of the evolving healthcare market, an important facet of understanding opportunity and strategy is effective definition and scoping of new terminology and concepts. Frost & Sullivan reviews data that illustrate there is often an inconsistent definition of the term as well as the companies that are participating in this early market. The research reveals that there is a much smaller segment of the digital therapeutics market devoted to pure play participants that are developing true therapeutic solutions that will provide a medical-grade benefit to patients. The pure play market will require considerable research and development in partnership with pharmaceutical companies, and a US Food and Drug Administration certification for safety and efficacy after a clinical trial.
Frost & Sullivan predicts that the digital therapeutics market will attract the interests of medical device companies, pharmaceutical industry participants, and investors. It is reasonable to foresee that several of the larger, established healthcare companies will carefully monitor progress in this space and make strategic moves as the smaller, new entrants demonstrate successful outcomes following randomized clinical trials.
Research Scope
The objective of this research service is to present an analysis of the US digital therapeutics market with respect to key market dynamics at play through 2023 and showcase select areas of opportunity in a landscape of related segments. The study describes and defines the digital therapeutics market and enabling technology; covers factors driving the need to deploy this emerging solution to enable improved patient outcome-based drug replacement, drug augmentation, and interactive communications platforms across a variety of specialties; examines challenges impacting the market; presents an outlook for the adoption of digital therapeutic services among key customer segments; presents Frost & Sullivan forecasts for overall market growth; and looks at opportunities in the total market and key market segments as estimated for the forecast period.
Key Issues Addressed
- What are pure play digital therapeutic services, and how are these solutions being deployed to patients, healthcare payers, employer plans, hospitals and physicians?
- What are the market-shifting macro trends affecting the need to deploy new digital therapeutic solutions to enable patients to achieve quality care in a variety of settings?
- What companies have a presence in the digital therapeutics market, either as pure play participants or within the wider view of the market?
- What are the segments of the digital therapeutics and digital health-related market, and which ones offer the best opportunities for growth?
- What is the 6-year revenue outlook for the digital therapeutics market and the major segments?
Key Findings
Scope and Segmentation
Market Engineering Measurements
CEO’s Perspective
3 Big Predictions
Digital Health Market Segmentation
Digital Therapeutics Origin
Digital Therapeutics
Key Definitions
Digital Therapeutics’ Position in Digital Health
Digital Therapeutics is Neither mHealth nor Digital Health
Pharma is Increasingly Interested in Digital Therapeutics
Digital Therapeutics and Pharmaceutical Companies
Digital Health Is Evolving from mHealth
mHealth Market Has Been Driven by Various Forces
Digital Health—Highest Impact Segments on Healthcare
Foundation for Digital Health and Therapeutics
Digital Therapeutics Technology Trends and Roadmap
Market Segmentation
Breaking Down the Segments
Digital Therapeutics and Health Areas of Progress
Digital Therapeutics Alliance
FDA Digital Health Software Precertification Program
Market Engineering Measurements
Full-Scale Market and Pure Play Solution Attributes
Pure Play Digital Therapeutics Market—Revenue Forecast
Total Digital Therapeutics Market—Revenue Forecast
Total Digital Therapeutics Market—Revenue Forecast by Segment
Total Digital Therapeutics Market—Revenue Share by Segment
Total Digital Therapeutics Market—Revenue Share Forecast by Segment
Chronic Condition Management Segment—Revenue Forecast
Behavior Management Segment—Revenue Forecast
Medication Adherence Support Segment—Revenue Forecast
Data Gathering and Analytics Segment—Revenue Forecast
Competitive Market Structure
Competitive Dynamics
The Digital Therapeutics Ecosystem—Technologies Add Value to Traditional Prescription-Based Treatments
Digital Therapeutics—Current and Potential Buyers
Business Models in Digital Therapeutics
Professional-Consumer Spectrum
Vendor Ecosystem
Pear Therapeutics
WellDoc
Chrono Therapeutics
Omada Health
Proteus Digital Health
Noom Inc.
MySugr (Roche Diabetes Care)
Click Therapeutics
Canary Health
CellScope
Virta Health
AliveCor
Apple, Inc.
Oscar Health Insurance Corporation
Big Health Ltd. (Sleepio)
Digital Services and Device Companies
Medical Device Companies and Digital Therapeutics
Lifestyle Services Companies and Digital Therapeutics
Payer Focused on Digital Therapeutics
Digital Medicine Investment Portfolio
Additional Digital Therapeutics Companies
5 Growth Opportunities Critical for Future Strategies
Levers for Growth
Growth Opportunity 1—Define Digital Therapeutics
Growth Opportunity 2—Increase Awareness of Digital Therapeutics
Growth Opportunity 3—Develop Business Models
Growth Opportunity 4—Develop Solutions for More Conditions
Growth Opportunity 5—Harness the Data
Strategic Imperatives for Digital Therapeutics
Technology—Future Impact on Digital Therapeutics
3 Big Predictions
Legal Disclaimer
List of Exhibits
Additional Frost & Sullivan Coverage of Telehealth
Selected Sources
List of Figures- 1. Total Digital Therapeutics Market: Market Engineering Measurements, US, 2017
- 2. Digital Therapeutics Market: Select Market Participants by Tiers of Competition, US, 2018
- 3. Digital Therapeutics Markets: Generic SWOT Analysis by Segment, US, 2018
- 4. Total Digital Therapeutics Market: Professional-Consumer Spectrum, US, 2018
List of Charts- 1. Total Digital Therapeutics Market: Market Engineering Measurements*, US, 2017
- 2. Digital Health Market: Market Segmentation, Global, 2017
- 3. Selected Telehealth/mHealth Markets with Highest Impact on Healthcare in the Next 5 Years, Top 2 Box, North America, 2014–2019
- 4. % of Doctors Using Smartphones and Medical Apps, US, 2015
- 5. % of Doctors Who Think Mobile Devices Expedite Decision-Making, US, 2015
- 6. % of Doctors Who Believe That mHealth Technologies Can Reduce Number of Office Visits, US, 2015
- 7. % Clinicians Using Mobile Technology to View Patient Information, US, 2015
- 8. % of Consumers Interested in mHealth Solutions, US, 2015
- 9. % of Doctors Who Prefer That Their Patients Monitor Health (Particularly Vitals) at Home, US, 2015
- 10. Digital Therapeutics Market: Tech Roadmap, US, 2018–2025
- 11. Total Digital Therapeutics Market: Market Segmentation, US, 2018
- 12. Pure Play Digital Therapeutics Market: Revenue Forecast, US, 2017–2023
- 13. Total Digital Therapeutics Market: Revenue Forecast, US, 2017–2023
- 14. Total Digital Therapeutics Market: Revenue Forecast by Segment, US, 2017–2023
- 15. Total Digital Therapeutics Market: Revenue Share by Segment, US, 2017
- 16. Total Digital Therapeutics Market: Revenue Share Forecast by Segment, US, 2023
- 17. Chronic Condition Management Segment: Revenue Forecast, US, 2017–2023
- 18. Behavior Management Segment: Revenue Forecast, US, 2017–2023
- 19. Medication Adherence Support Segment: Revenue Forecast, US, 2017–2023
- 20. Data Gathering and Analytics Segment: Revenue Forecast, US, 2017–2023
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023.
This report emphasizes the importance of clearly defining the term "digital therapeutics." In many areas of the evolving healthcare market, an important facet of understanding opportunity and strategy is effective definition and scoping of new terminology and concepts. Frost & Sullivan reviews data that illustrate there is often an inconsistent definition of the term as well as the companies that are participating in this early market. The research reveals that there is a much smaller segment of the digital therapeutics market devoted to pure play participants that are developing true therapeutic solutions that will provide a medical-grade benefit to patients. The pure play market will require considerable research and development in partnership with pharmaceutical companies, and a US Food and Drug Administration certification for safety and efficacy after a clinical trial.
Frost & Sullivan predicts that the digital therapeutics market will attract the interests of medical device companies, pharmaceutical industry participants, and investors. It is reasonable to foresee that several of the larger, established healthcare companies will carefully monitor progress in this space and make strategic moves as the smaller, new entrants demonstrate successful outcomes following randomized clinical trials.--BEGIN PROMO--
Research Scope
The objective of this research service is to present an analysis of the US digital therapeutics market with respect to key market dynamics at play through 2023 and showcase select areas of opportunity in a landscape of related segments. The study describes and defines the digital therape
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Table of Contents | | Executive Summary~ || Key Findings~ || Scope and Segmentation~ || Market Engineering Measurements~ || CEO’s Perspective~ || 3 Big Predictions~ | Digital Therapeutics Market—Defining a Promising Opportunity~ || Digital Health Market Segmentation~ || Digital Therapeutics Origin~ || Digital Therapeutics~ || Key Definitions~ || Digital Therapeutics’ Position in Digital Health~ || Digital Therapeutics is Neither mHealth nor Digital Health~ || Pharma is Increasingly Interested in Digital Therapeutics~ || Digital Therapeutics and Pharmaceutical Companies~ || Digital Health Is Evolving from mHealth~ || mHealth Market Has Been Driven by Various Forces~ || Digital Health—Highest Impact Segments on Healthcare~ || Foundation for Digital Health and Therapeutics~ || Digital Therapeutics Technology Trends and Roadmap~ | The Early Digital Therapeutics Market~ || Market Segmentation~ || Breaking Down the Segments~ || Digital Therapeutics and Health Areas of Progress~ || Digital Therapeutics Alliance~ || FDA Digital Health Software Precertification Program~ | Forecasts and Trends—Total Market and Segment Analysis~ || Market Engineering Measurements~ || Full-Scale Market and Pure Play Solution Attributes~ || Pure Play Digital Therapeutics Market—Revenue Forecast~ || Total Digital Therapeutics Market—Revenue Forecast~ || Total Digital Therapeutics Market—Revenue Forecast by Segment~ || Total Digital Therapeutics Market—Revenue Share by Segment~ || Total Digital Therapeutics Market—Revenue Share Forecast by Segment~ || Chronic Condition Management Segment—Revenue Forecast~ || Behavior Management Segment—Revenue Forecast~ || Medication Adherence Support Segment—Revenue Forecast~ || Data Gathering and Analytics Segment—Revenue Forecast~ | Competitive Environment~ || Competitive Market Structure~ || Competitive Dynamics~ || The Digital Therapeutics Ecosystem—Technologies Add Value to Traditional Prescription-Based Treatments~ || Digital Therapeutics—Current and Potential Buyers~ || Business Models in Digital Therapeutics~ || Professional-Consumer Spectrum~ || Vendor Ecosystem~ | Pure Play Digital Therapeutics Companies~ || Pear Therapeutics~ || WellDoc~ || Chrono Therapeutics~ || Omada Health~ || Proteus Digital Health~ || Noom Inc.~ || MySugr (Roche Diabetes Care)~ || Click Therapeutics~ || Canary Health~ || CellScope~ || Virta Health~ | Adjacent Market Participants~ || AliveCor~ || Apple, Inc.~ || Oscar Health Insurance Corporation~ || Big Health Ltd. (Sleepio)~ || Digital Services and Device Companies~ || Medical Device Companies and Digital Therapeutics~ || Lifestyle Services Companies and Digital Therapeutics~ || Payer Focused on Digital Therapeutics~ || Digital Medicine Investment Portfolio~ | Additional Market Entrants—Digital Therapeutics Initiatives~ || Additional Digital Therapeutics Companies~ | Growth Opportunities~ || 5 Growth Opportunities Critical for Future Strategies~ || Levers for Growth~ || Growth Opportunity 1—Define Digital Therapeutics~ || Growth Opportunity 2—Increase Awareness of Digital Therapeutics~ || Growth Opportunity 3—Develop Business Models~ || Growth Opportunity 4—Develop Solutions for More Conditions~ || Growth Opportunity 5—Harness the Data~ || Strategic Imperatives for Digital Therapeutics~ | Future Perspectives~ || Technology—Future Impact on Digital Therapeutics~ || 3 Big Predictions~ || Legal Disclaimer~ | Appendix~ || List of Exhibits~ || Additional Frost & Sullivan Coverage of Telehealth~ || Selected Sources~ | The Frost & Sullivan Story~ |
| List of Charts and Figures | 1. Total Digital Therapeutics Market: Market Engineering Measurements, US, 2017~ 2. Digital Therapeutics Market: Select Market Participants by Tiers of Competition, US, 2018~ 3. Digital Therapeutics Markets: Generic SWOT Analysis by Segment, US, 2018~ 4. Total Digital Therapeutics Market: Professional-Consumer Spectrum, US, 2018~| 1. Total Digital Therapeutics Market: Market Engineering Measurements*, US, 2017~ 2. Digital Health Market: Market Segmentation, Global, 2017~ 3. Selected Telehealth/mHealth Markets with Highest Impact on Healthcare in the Next 5 Years, Top 2 Box, North America, 2014–2019~ 4. % of Doctors Using Smartphones and Medical Apps, US, 2015~ 5. % of Doctors Who Think Mobile Devices Expedite Decision-Making, US, 2015~ 6. % of Doctors Who Believe That mHealth Technologies Can Reduce Number of Office Visits, US, 2015~ 7. % Clinicians Using Mobile Technology to View Patient Information, US, 2015~ 8. % of Consumers Interested in mHealth Solutions, US, 2015~ 9. % of Doctors Who Prefer That Their Patients Monitor Health (Particularly Vitals) at Home, US, 2015~ 10. Digital Therapeutics Market: Tech Roadmap, US, 2018–2025~ 11. Total Digital Therapeutics Market: Market Segmentation, US, 2018~ 12. Pure Play Digital Therapeutics Market: Revenue Forecast, US, 2017–2023~ 13. Total Digital Therapeutics Market: Revenue Forecast, US, 2017–2023~ 14. Total Digital Therapeutics Market: Revenue Forecast by Segment, US, 2017–2023 ~ 15. Total Digital Therapeutics Market: Revenue Share by Segment, US, 2017~ 16. Total Digital Therapeutics Market: Revenue Share Forecast by Segment, US, 2023~ 17. Chronic Condition Management Segment: Revenue Forecast, US, 2017–2023~ 18. Behavior Management Segment: Revenue Forecast, US, 2017–2023 ~ 19. Medication Adherence Support Segment: Revenue Forecast, US, 2017–2023~ 20. Data Gathering and Analytics Segment: Revenue Forecast, US, 2017–2023~ |
| Author | Victor Camlek |
| Industries | Healthcare |
| WIP Number | K270-01-00-00-00 |
| Keyword 1 | Digital Therapeutics |
| Is Prebook | No |
| GPS Codes | 9564-B1,9600-B1,9612-B1 |
Similar Research
Check items to add to the cart or
